Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Feb 2024. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5304845017 | Product containing only dapagliflozin and saxagliptin (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5304846016 | Dapagliflozin and saxagliptin only product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only dapagliflozin and saxagliptin (medicinal product) | Is a | Dapagliflozin- and saxagliptin-containing product | true | Inferred relationship | Some | ||
| Product containing only dapagliflozin and saxagliptin (medicinal product) | Plays role | Antidiabetic therapeutic role (role) | false | Inferred relationship | Some | ||
| Product containing only dapagliflozin and saxagliptin (medicinal product) | Has active ingredient | Saxagliptin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only dapagliflozin and saxagliptin (medicinal product) | Has active ingredient | Dapagliflozin (substance) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only dapagliflozin and saxagliptin in oral dose form (medicinal product form) | Is a | True | Product containing only dapagliflozin and saxagliptin (medicinal product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR